Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters











Database
Language
Publication year range
1.
Animals (Basel) ; 14(11)2024 Jun 04.
Article in English | MEDLINE | ID: mdl-38891723

ABSTRACT

This study evaluated the effects of Pediococcus pentosaceus GT001 on Salmonella typhimurium (S. typhimurium)-challenged broiler chickens. Two hundred Ross 708 broiler day-old chicks with comparable weight were distributed at random into four treatments with five replicates and ten chicks per replicate. The following were the treatment groups: (B) basal diet (control); (B + S) basal diet and birds were challenged with S. typhimurium at 1.0 × 107 cfu/g; (B + P) basal diet + Pediococcus pentosaceus GT001 at 4.0 × 108 cfu/g; (B + P + S) basal diet + P. pentosaceus GT001 at 4.0 × 108 cfu/g and birds were challenged with S. typhimurium at 1.0 × 107 cfu/g. There was a significant reduction (p < 0.05) in the body weight of the Salmonella-infected birds compared to the other treatment groups. However, the FCRs of the broilers were comparable among the different treatment groups (p > 0.05). The lipid profile and liver function indices measured were significantly enhanced in the P. pentosaceus GT001-supplemented groups (B + P and B + P + S) compared to the group that was Salmonella-challenged (p < 0.05) but were similar to those in the control group. The serum antioxidant activities, such as the T-AOC, SOD, CAT, GHS-Px and MDA, were significantly improved in the P. pentosaceus GT001-supplemented groups (B + P and B + P + S) (p < 0.05). The MDA was similar in the B + P and B + P + S groups, but both were significantly lower than the control and the Salmonella groups. The administration of P. pentosaceus GT001 enhanced the lipase and amylase levels in both the serum and intestine of the broilers (p < 0.05). The immunoglobin (IgA, IgG, IgM) and cytokine (IL-10 and IL-6) levels in the serum were significantly higher in the B, B + P and B + P + S treatment groups (p < 0.05). The immune-related organs (bursa and spleen) were significantly influenced in the birds fed with P. pentosaceus GT001. No significant variation was noted among all the dietary treatments in terms of the measured meat quality indices. The small intestinal digesta content of the Salmonella load was below a detectable range after 14 days of infection (p < 0.05). No significant differences were observed among the different treatment groups in terms of the breast pH, drip loss and meat color (p > 0.05). The inclusion of P. pentosaceus GT001 also modified the community structure in the cecum. This indicates that it has health benefits and could be incorporated in the broiler diet.

2.
Trop Anim Health Prod ; 54(1): 75, 2022 Jan 25.
Article in English | MEDLINE | ID: mdl-35075544

ABSTRACT

Genetic improvement in commercial broilers worldwide is heavily focused on selection for higher final body weight at a given age. Although commercial broilers are mostly sold by their final body weight, it is important to carefully consider how this weight is attained and at what cost. The cost of feeding broilers, which constitutes about 70% of the total cost of broiler production, varies considerably at different stages of the bird. Careful consideration of the growth curve of broilers and the parameters of the growth curve is critical to optimize profitability of commercial broiler production. The objective of this study was to model the variations of the growth curves of 4 commercial broiler genotypes reared in Ghana using the Gompertz and polynomial growth functions. Data on body weights at 1, 7, 14, 21, 28, 35, and 42 days for 4 unsexed commercial broiler genotypes were used to model both the Gompertz and polynomial growth functions. The 4 genotypes ranked differently for Gompertz predicted early (1-28 days), late growth (28-42 days), and body weight at 42 days. Gompertz function predicted growth better for broiler chicken than the polynomial as the parameters of the Gompertz function are biologically meaningful and heritable. Selection of broiler genotypes for production based on their growth curve (slower early growth and faster late growth) could minimize cost of production and thereby increase the profitability of commercial broiler production in the tropics.


Subject(s)
Chickens , Animals , Body Weight , Chickens/genetics , Genotype , Ghana
3.
J Complement Integr Med ; 13(3): 239-245, 2016 Sep 01.
Article in English | MEDLINE | ID: mdl-27352448

ABSTRACT

BACKGROUND: The leaves of Pergularia daemia Forsk (family Asclepidaceae) provide alternative plant-based treatments for the management of diabetes mellitus and diarrhoea in both humans and indigenous poultry species like the Guinea fowls (Numida meleagris). However, no scientific investigations to validate its usefulness in Ghana have been established. This study therefore sought to investigate the anti-hyperglycaemic activity of the 70 % ethanolic extract of P. daemia using streptozotocin (STZ)-induced diabetic male Sprague-Dawley rats. Additionally, the antioxidant and antimicrobial properties of the extract were investigated. METHODS: The total phenolic content, total flavonoids content, radical scavenging activity and reducing power assays were estimated using Folin-Ciocalteu method, aluminium chloride colorimetric assay, Fe3+ reduction assay and 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging assays, respectively. RESULTS: The results showed that P. daemia extract caused anti-hyperglycaemic activity in the STZ-induced rats at doses of 30, 60 and 90 mg/kg body weight with significant reduction in blood glucose levels. The phytosterols, saponins, phenols, alkaloids, tannins and triterpenes found in the extract may be responsible for the observed anti-hyperglycaemia and antioxidant activities. The extract also showed antimicrobial activity against Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus and Bacillus subtilis. CONCLUSIONS: These findings justify the folkloric use of P. daemia as an anti-diabetic and antibacterial agents for susceptible species.


Subject(s)
Anti-Bacterial Agents/pharmacology , Antioxidants/pharmacology , Apocynaceae/chemistry , Bacteria/drug effects , Diabetes Mellitus, Experimental/blood , Hypoglycemic Agents/pharmacology , Plant Extracts/pharmacology , Animals , Anti-Bacterial Agents/analysis , Anti-Bacterial Agents/therapeutic use , Antioxidants/therapeutic use , Biphenyl Compounds/metabolism , Blood Glucose/metabolism , Diabetes Mellitus, Experimental/drug therapy , Flavonoids/analysis , Flavonoids/pharmacology , Flavonoids/therapeutic use , Ghana , Hypoglycemic Agents/analysis , Hypoglycemic Agents/therapeutic use , Male , Phenols/analysis , Phenols/pharmacology , Phenols/therapeutic use , Phytotherapy , Picrates/metabolism , Plant Extracts/chemistry , Plant Extracts/therapeutic use , Plant Leaves/chemistry , Rats, Sprague-Dawley
SELECTION OF CITATIONS
SEARCH DETAIL